Navigation Links
Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
Date:11/20/2012

DUNDEE, Scotland, November 20, 2012 /PRNewswire/ --

Mr Shaper FRCS, Consultant Vascular Surgeon at Bradford Royal Infirmary, said, "The study showed significantly encouraging initial results for the use of Spiral Laminar Flow[TM] grafts in lower extremity bypasses to warrant continued usage and further long term data acquisition."

Initial results, from the on-going study, were presented at the 39th Annual Veith Symposium on Friday 16th November, 2012 in New York, USA. The study followed up the implantation of 31 Spiral Flow[TM] peripheral vascular grafts (Vascular Flow Technologies, Dundee, UK) between February 2011 to October 2012 with prospective data on-going and a retrospective analysis of 136 conventional ePTFE grafts  from same unit implanted between January 2003 to December 2008. The comparison presented was based on 1 year data available on 114 conventional PTFE grafts and 12 SLF[TM] grafts. The patients all had lower extremity bypasses.

     (Photo: http://photos.prnewswire.com/prnh/20121120/577588 )

The study showed that primary patency for the SLF[TM] graft was 92% compared to 48% for the conventional PTFE graft and secondary patency 100% for the SLF[TM] graft compared to 55% for the conventional PTFE graft. The amputation rate in the SLF[TM] graft group was 0% compared to 10% for the conventional graft group.

The innovative design of the Spiral Flow[TM] Graft is different from all other prosthetic vascular grafts. Near the distal end of the graft there is a 'Spiral Flow Inducer'- an ePTFE helical ridge on the graft lumen which remodels turbulent blood flow created by diseased vesse
'/>"/>

SOURCE Vascular Flow Technologies
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Two Top Notch Cadaver Workshops Offered by joimax® in April
3. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
4. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
5. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
6. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
7. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
8. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
9. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
10. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
11. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
(Date:12/24/2014)... -- Commonwealth Cornerstone Group (CCG) today announced the completion of an ... help fund the expansion and consolidation of healthcare services provided ... . PHN is the largest federally qualified ... is the largest employer in Sharon,s ... Currently, PHN Sharon offers scattered services out of ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, iFitDress.com, the ... for women, has announced its new selection of black ... are on sale now; they are available at discounted prices, ... says, “The promotion will last for three weeks only. You ... market. Those who are interested in our new items can ...
(Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
(Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
(Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... cancers that respond best to tyrosine kinase inhibitors (TKIs), ... according to research presented at the 14th World Conference ... Association for the Study of Lung Cancer (IASLC). ... for non-small cell lung cancer therapy, selecting the best ...
... common type of liver cancer, is a leading cause ... options available, they are largely unsuccessful because the disease ... HCC, combined with studies using mice and other animal ... how to diagnose and treat this deadly form of ...
... therapy helps ease chronic low back pain and improve function, ... of Internal Medicine will publish in its July 5 ... massage, the trial found that both types of massage worked ... helps people with back pain to function even after six ...
... are two to three times more likely to develop a life-threatening ... study published on bmj.com today. The new ... your risk of developing a pulmonary embolism a common cause ... says that, although the risk is small equivalent to seven ...
... Recent studies have revealed potato chips and french fries to ... good reason. Have you ever wondered why you can,t eat ... the carbohydrates at fault. UC Irvine researchers Daniele Piomelli, ... make them nearly irresistible and trigger a surprising biological mechanism ...
... smoking is associated with a 72% increased risk of ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo link ... cause of serious illness and death in smokers and ... Varenicline is one of the most commonly used drugs ...
Cached Medicine News:Health News:PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors 2Health News:Research in fish provides new clues about deadly form of liver cancer 2Health News:Massage eases low back pain in randomized controlled trial 2Health News:Massage eases low back pain in randomized controlled trial 3Health News:Sitting for long periods doubles risk of blood clots in the lungs 2Health News:Body's natural marijuana-like chemicals make fatty foods hard to resist 2Health News:Varenicline for smoking cessation linked to increased risk of serious harmful cardiac events 2
Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
Used for injection into urethral strictures, bladder neck contracture, and the bladder wall. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: